DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Monterey, CA

9 verified pulmonary disease doctors in Monterey.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Medical Board of California

Dr. Georgina Heal, MD

Pulmonary Disease

20 yrs NPPES
NPI 1639129901
2 UPPER RAGSDALE DR STE B270, Monterey, CA 93940(831) 324-0593
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,033 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,033

Total received

45

Transactions

16

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$150.34
AstraZeneca Pharmaceuticals LP$146.63
Mylan Specialty L.P.$100.26
Amgen Inc.$95.45
Takeda Pharmaceuticals U.S.A., Inc.$91.92
Insmed, Inc.$74.96

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 80th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Georgina Heal do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Richard Kanak, MD

Pulmonary Disease

20 yrs NPPES
NPI 1508817776
2 UPPER RAGSDALE DR BLDG A, Monterey, CA 93940(831) 333-3040
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,181 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,181

Total received

16

Transactions

8

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$323.91
Jazz Pharmaceuticals Inc.$233.52
Abbott Laboratories$160.40
GlaxoSmithKline, LLC.$140.80
IDORSIA PHARMACEUTICALS US INC$105.89
Harmony Biosciences LLC$99.77

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 81th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Richard Kanak do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Marta Zulik, MD

Pulmonary Disease

20 yrs NPPES
NPI 1578588554
23625 HOLMAN HWY, Monterey, CA 93940(209) 464-6422
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Najwa Bahu Baugh, MD

Pulmonary Disease

20 yrs NPPES
NPI 1891893657
5 LOWER RAGSDALE DR STE 100, Monterey, CA 93940(831) 649-3375
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,790 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,790

Total received

69

Transactions

15

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$765.73
Genzyme Corporation$156.78
GlaxoSmithKline, LLC.$138.20
Harmony Biosciences LLC$120.63
Actelion Pharmaceuticals US, Inc.$104.73
sanofi-aventis U.S. LLC$98.00

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 85th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Najwa Bahu Baugh do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Mark Garfield, MD

Pulmonary Disease

20 yrs NPPES
NPI 1669555355
2 UPPER RAGSDALE DR BLDG A, Monterey, CA 93940(831) 333-3040
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,472 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,472

Total received

106

Transactions

23

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$504.09
Grifols USA, LLC$367.71
AstraZeneca Pharmaceuticals LP$296.46
Boehringer Ingelheim Pharmaceuticals, Inc.$183.22
Mylan Specialty L.P.$159.78
Electromed, Inc.$104.18

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 88th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Mark Garfield do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Kenneth Juenger, MD

Pulmonary Disease

15 yrs NPPES
NPI 1336436039
2 UPPER RAGSDALE DR BLDG A, Monterey, CA 93940(831) 333-3040
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Antonette Ajayi, MD

Pulmonary Disease

12 yrs NPPES
NPI 1225456643
2 UPPER RAGSDALE DR BLDG A, Monterey, CA 93940(831) 333-3040
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $228.77 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$228.77

Total received

3

Transactions

3

Paying companies

Top paying companies

Ambu Inc.$160.46
sanofi-aventis U.S. LLC$52.99
AstraZeneca Pharmaceuticals LP$15.32

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 66th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Antonette Ajayi do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Sky Vanderburg, MD

Pulmonary Disease

11 yrs NPPES
NPI 1366838237
2 UPPER RAGSDALE DR BLDG A, Monterey, CA 93940(831) 333-3040
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Paul Montgomery, MD

Pulmonary Disease

10 yrs NPPES
NPI 1124489539
2 UPPER RAGSDALE DR BLDG A, Monterey, CA 93940(831) 333-3040
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $95.64 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$95.64

Total received

2

Transactions

2

Paying companies

Top paying companies

Genzyme Corporation$77.81
Merck Sharp & Dohme LLC$17.83

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 57th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Paul Montgomery do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Monterey, CA — Verified | DoctorsProof | DoctorsProof